Oncolytics Biotech Inc T.ONC

Wow factor still there

[SundayMovies]

The primary end point was met and that's what we got (16 weeks) 50%+. 
We learned that PIII will be 2 arm study. PX vs. PX+Pela (much cheaper and faster trial than 3 arm). 

Adlai Nortye wow us will CR and PR. 

On Sunday, we get more data and this is the wow factor that the market was looking for week. 

This should add a decent dollar or two to valuation. After that, blue skies. You sit on your profit and you wait.

[13X2413]

I have the wow factor too. Wow, my money is disappearing. US market should stay closed. Yesterday looked so promising.  What is it that investors don't like? Many on this board still holding out hope for a miracle, including me.  Wish I could see through all this medical lingo which could explain what many don't like. 

[Buckhenry]

I think the only way to make money on this stock is buy the dips and set yourself  a target  and sell and wait  fir it to go back down. I see huge huge swings ahead. If your waiting for the big kuhuna your going to leave alot of money on the table and it may never happen.  Dreamers on here have gotten way off target as this is a stock site not a medical journal site. 

[13X2413]

What happened to that $9 target someone put in this? Wonder if that's still on the table?

[Azzak34]

It's difficult to pin point the dumbest sentence in this little back and forth. But a Biotech stock needs investors to know the "medical lingo" as the stock is almost entirely dependent on those result thingies. 

[13X2413]

Damn. I'm so dumb. Didn't realize you had to be a medical expert to decipher the news that whacked this stock.  I should stick to what I know.........nothing! ;)

[Buckhenry]

This stock has a good trading range so there is good money to be made. The only ignorance here is folks holding for years and leaving all that money on the table 

[Azzak34]

Do you have a blog or something we can all subscribe to? Or an only fans? 

[westcoast1000]

Azzak, preety funny! you are very good at this kind of repartee. I guess I miss a lot of funny lines by muting annoying posters, but at least I get the good half of the conversation.

[Quentin30]

It looks unlikely that mBC will advance into a Phase III trial without a checkpoint inhibitor (i.e. Avelumab). So that means there is no value proposition for the CPI company to make any offer, they'll just walk away... All the pumping about valuation on here, has been about what Pela is worth to the CPI company, because if it enables the CPI to work in combo, whereas before it did not, it